Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics - A phase II multicenter study

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 5, 1996, Pages 1137-1145

  Antognoni, Paolo ^a   Bignardi, Mario ^b   Cazzaniga, Franco ^c   Poli, A Marisa ^d   Richetti, Antonella ^a   Bossi, Alberto ^c   Rampello, Giuseppina ^d   Barbera, Fernando ^b   Soatti, Carlo ^b   Bardelli, Donata ^a   Giordano, Monica ^c   Danova, Marco ^e,f  

^a Ospedale Multizonale Varese   (Italy)

^b Spedali Civili   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

^d Divisione di Radioterapia   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f CNR   (Italy)

Author keywords

Accelerated fractionation; BrdUrd (5 bromo 2 deoxyuridine); Cell kinetics; Head and neck cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CELL KINETICS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTICENTER STUDY; OROPHARYNX CARCINOMA; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; SALIVARY GLAND DISEASE; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; DNA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; SURVIVAL RATE;

EID: 17744410188     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00403-8     Document Type: Article

References (52)

1. 1. Amdur, R.; Parson, J.; Mendenhall, W.; Million, R.; Cassisi, N. Split-course vs. continuous course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 17:279-285; 1989.
2. 2. Ang, K. K.; Peters, L. J.; Weber, R. S.; Maor, M. H.; Morrison, W. H.; Wendt, C. D.; Brown, B. W. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 19:1339-1345; 1990.
3. 3. Barton, M.; Keane, T.; Gadalla, T.; Maki, E. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of oropharyngeal cancer. Radiother. Oncol. 23:137-143; 1992.
4. 4. Begg, A. C. Critical appraisal of in situ cell kinetic measurements as response predictors in human tumors. Semin. Radiat. Oncol. 3:144-151; 1993.
5. 5. Begg, A. C.; Hofland, L.; Van Glabbeke, M.; Bartelink, H.; Horiot, J. C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 2:22-25; 1992.
6. 6. Begg, A. C.; McNally, N. J. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620-623; 1985.
7. 7. Begg, A. C.; Moonen, L.; Hofland, I.; Dessing, M.; Bartelink, H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumoral sampling variations. Radiother. Oncol. 11:337-347; 1988.
8. 8. Bennett, M.; Wilson, G.; Dische, S.; Saunders, M.; Martindale, C.; O'Halloran, A. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65:870-878; 1992.
9. 9. Bourhis, J; Wilson, G.; Wibault, P.; Bosq, J.; Chavaudra, N.; Janot, F.; Luboinski, B.; Eschwege, F.; Malaise, E. P. In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26:793-799; 1993.
10. 10. Brodin, O. The doubling time of human tumours during radiotherapy: An analysis based on comparison between clinical and in vitro tumour cell radioresponsiveness. Radiat. Oncol. Invest. 2:99-108; 1994.
11. 11. Corvò, R.; Giaretti, W.; Sanguineti, G.; Geido, E.; Orecchia, R.; Barra, S.; Margarine, G.; Bacigalupo, A.; Vitale, V. Potential doubling time in head and neck tumors treated by primary radiotherapy: Preliminary evidence for prognostic significance in local control. Int. J. Radiat. Oncol. Biol. Phys. 27:1165-1172; 1993.
12. 12. Dische, S. Conference summary. The twenty-third annual San Francisco cancer symposium, March 4-5, 1989. Radiation tolerance of normal tissues. In: Vaeth, J. M.; Meyer, J. L., eds. Front. Radiat. Ther. Oncol. Vol. 23. Basel, Switzerland: Karger; 1989:419-427.
13. 13. Dische, S.; Saunders, M. Continuous hyperfractionated accelerated radiotherapy (CHART): An interim report upon late morbidity. Radiother. Oncol. 16:67-74; 1989.
14. 14. Dobrowsky, W. Unconventional fractionation with or without mitomycin C in advanced head and neck cancer. Semin. Radiat. Oncol. 2:45-47; 1992.
15. 15. Ensley, J. F.; Maciorowski, Z. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Semin. Radiat. Oncol. 21:330-339; 1994.
16. 16. Fowler, J. F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother. Oncol. 18:165-181; 1990.
17. 17. Fowler, J. F. Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment - Continually rapid repopulation unmasked. Radiother. Oncol. 22:156-158; 1991.
18. 18. Fowler, J. F.; Lindstrom, M. Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23:457-467; 1992.
19. 19. Harari, P. Adding dose escalation to accelerated hyperfractionation for head and neck cancer: 76 Gy in 5 weeks. Semin. Radiat. Oncol. 2:58-61; 1992.
20. pot) be compared between laboratories? A quality control study. Cytometry 19:154-163; 1995.
21. 21. Hendry, J. H.; Roberts, S. A.; Slevin, N. J.; Keane, T. J.; Barton, M. B.; Agren-Cronqvist, A. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centres in Manchester, UK and Toronto, Canada. Radiother. Oncol. 31:14-22; 1994.
22. 22. Horiot, J. C.; Le Fur, R.; Nguyen, T.; Chenal, C.; Schraub, S.; Alfonsi, S.; Gardani, G.; Van Den Bogaert, W.; Danczak, S.; Bolla, M.; Van Glabbeke, M.; De Pauw, M. Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25:231-241; 1992.
23. 23. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements; 1992:18-26.
24. 24. Kaanders, J. H. A. M.; Ang, K. K. Early reactions as dose-limiting factors in radiotherapy. Semin. Radiat. Oncol. 4:55-67; 1994.
25. 25. Kaplan, E. L.; Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
26. 26. Kocagoncu, K. O.; Marangoni, G.; Cozzi-Fogliata, A.; Griffin, S.; Garavaglia, G.; Thum, P.; Bernier, J.; and the Cooperative Group for Predictive Tests in Radiobiology. Intrinsic radiosensitivity of head and neck carcinomas as predictive test for clinical tumor control: Comparative analysis and critical assessment of technical reliability. Radiat. Oncol. Invest. 2:177-184; 1994.
27. 27. Lamb, D. S.; Spry, N. A.; Gray, A. J.; Johnson, A. D.; Alexander, S. R.; Dally, M. J. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother. Oncol. 18:107-116; 1990.
28. 28. Lochrin, C. A.; Wilson, G. D.; McNally, N. J.; Dische, S.; Saunders, M. I. Tumor cell kinetics, local tumor control, and accelerated radiotherapy: A preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 24:87-91; 1992.
29. 29. Lusinchi, A.; Lartigau, E.; Luboinski, B.; Eschwege, F. Accelerated radiation therapy in the management of very advanced and inoperable head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 29:149-152; 1994.
30. 30. Lutgens, L. C. H. W.; Schutte, B.; de Jong, J. M. A.; Thunnissen, F. B. J. M. DNA content as prognostic factor in cervix carcinoma stage I B-III treated with radiotherapy. Gynecol. Oncol. 54:275-281; 1994.
31. 31. Marcial, V. A.; Pajak, T. F.; Chang, C.; Tupchong, L.; Stetz, J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx and sinuses, using radiation therapy as the only planned modality: (Preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int. J. Radiat. Oncol. Biol. Phys. 13:41-47; 1987.
32. 32. Mendenhall, W.; Parson, J.; Million, R.; Fletcher, G. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: Relationship of dose-fractionation factors to local control and complications. Int. J. Radiat. Oncol. Biol. Phys. 15:1267-1273; 1988.
33. 33. Nguyen, T. D.; Demange, L.; Froissart, D.; Panis, X.; Loirette, M. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck. Cancer 56:16-19; 1985.
34. 34. Nylander, K.; Anneroth, G.; Gustafsson, H.; Roos, G.; Stenling, R.; Zackrisson, B. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol. 3:23-28; 1994.
35. 35. Olmi, P.; Cellai, E.; Chiavacci, A.; Fallai, C. Accelerated fractionation in advanced head and neck cancer: Results and analysis of late sequelae. Radiother. Oncol. 17:199-207; 1990.
36. 36. Overgaard, J.; Hjelm-Hansen, M.; Vendelbo, J. Comparison of conventional and split-course as primary treatment in carcinoma of the larynx. Acta Oncol. 27:147-161; 1988.
37. 37. Peracchia, G.; Salti, C. Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences. Int. J. Radiat. Oncol. Biol. Phys. 7:99-104; 1981.
38. 38. Peto, R.; Pike, M. C.; Armitage, P.; Breslow, N. E.; Cox, D. R.; Howard, S. V.; Mantel, N.; McPherson, K.; Peto, J.; Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br. J. Cancer 35:1-39; 1977.
39. 39. Pinto, L. H. J.; Canary, P. C. V.; Araujo, C. M. M.; Bacelar, S. C.; Souhami, L. Prospective randomized trial comparing hyperfractionated vs. conventional radiotherapy in stage III and IV oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 21:557-562; 1991.
40. 40. Riccardi, A.; Danova, M.; Ascari, E. Bromodeoxyuridine for cell kinetic investigations in humans. Haematologica 73:423-430; 1988.
41. 41. Saunders, M. I.; Dische, S.; Grosch, E. J.; Fermont, D. C.; Ashford, R. F. U.; Maher, E. J.; Makepeace, A. R. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 21:871-878; 1991.
42. 42. Schmid-Ullrich, R.; Johnson, C.; Wazer, D. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 21:563-568; 1991.
43. 43. Taylor, J.; Withers, H.; Mendenhall, W. Dose-time consideration of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17:95-102; 1990.
44. 44. Terry, N. H. A.; White, R. A.; Meistrich, M. L.; Calkins, D. P. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry 12:234-241; 1991.
45. 45. Thames, H.; Hendry, J. Proliferative response to radiation injury. In: Thames, H.; Hendry, J., eds. Fractionation in radiotherapy. London, UK: Taylor & Francis; 1987:125-126.
46. 46. Thames, H. D.; Peters, L.; Withers, H.; Fletcher, G. Accelerated fractionation vs. hyperfractionation: Rationales for several treatments per day. Int. J. Radiat. Oncol. Biol. Phys. 9:127-132; 1983.
47. 47. Trott, K.; Kummermehr, J. Rapid repopulation in radiotherapy: Debate on mechanism, accelerated repopulation in tumor and normal tissue. Radiother. Oncol. 22:159-160; 1991.
48. 48. van Putten, W. L. J.; van der Saugen, M. J. C.; Hoekstra, C. J. M.; Levendag, P. C. Dose, fractionation and overall treatment time in radiation therapy - The effects on local control for cancer of the larynx. Radiother. Oncol. 30:97-108; 1994.
49. 49. Wang, C. C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int. J. Radiat. Oncol. Biol. Phys. 14:1143-1146; 1988.
50. 50. Wiernik, G.; Alcock, C. J.; Bates, T. D.; Brindle, J. M.; Fowler, J. F.; Gajek, W. R.; Goodman, S.; Haybitte, J. L.; Henk, J. M.; Hopewell, J. W.; Hunter, R. D.; Lindup, R.; Phillips, D. L.; Rezvani, M. Final report on the second British Institute of Radiology fractionation study: Short vs. long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br. J. Radiol. 64:232-241; 1991.
51. 51. Wilson, G. D.; McNally, N. J.; Dische, S.; Bennett, M. Cell proliferation in human tumours measured by in vivo labelling with bromodeoxyuridine. Br. J. Cancer 58:423-431; 1988.
52. 52. Withers, H.; Taylor, J.; Maciejevski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.